Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.22B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Danaher
DHR
|
+$293M |
| 4 |
Linde
LIN
|
+$281M |
| 5 |
Carlyle Group
CG
|
+$268M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$926M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$770M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$649M |
| 4 |
Meta Platforms (Facebook)
META
|
+$641M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$462M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.07% |
| 2 | Financials | 9% |
| 3 | Technology | 7.77% |
| 4 | Healthcare | 6.87% |
| 5 | Industrials | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
PUT
PVH
PVH
$3.49B
| $2.62M | ﹤0.01% |
+40,600
| New | +$3.28M |
|
|
MOFG
3402
DELISTED
MidWestOne Financial Group
MOFG
| $2.62M | ﹤0.01% |
88,608
-22,369
| -20% | -$675K |
|
3403
South Plains Financial
SPFI
$823M
| $2.62M | ﹤0.01% |
79,173
-15,159
| -16% | -$522K |
|
3404
Praxis Precision Medicines
PRAX
$9.63B
| $2.62M | ﹤0.01% |
69,181
-81,711
| -54% | -$5.1M |
|
3405
Immunovant
IMVT
$8.51B
| $2.62M | ﹤0.01% |
153,240
+6,143
| +4% | +$129K |
|
3406
Enliven Therapeutics
ELVN
$4.24B
| $2.62M | ﹤0.01% |
132,887
+82,083
| +162% | +$1.77M |
|
3407
CVB Financial
CVBF
$3.91B
| $2.62M | ﹤0.01% |
141,669
-34,996
| -20% | -$697K |
|
3408
Tompkins Financial
TMP
$1.41B
| $2.61M | ﹤0.01% |
41,520
+20,522
| +98% | +$1.37M |
|
3409
PUT
XPO
XPO
$22.1B
| $2.61M | ﹤0.01% |
24,300
+14,300
| +143% | +$1.82M |
|
3410
CALL
Viatris
VTRS
$18.8B
| $2.61M | ﹤0.01% |
+300,000
| New | +$3.15M |
|
3411
PUT
Coca-Cola Europacific Partners
CCEP
$48.2B
| $2.61M | ﹤0.01% |
+30,000
| New | +$2.45M |
|
|
PPLI
3412
People Inc
PPLI
$2.91B
| $2.61M | ﹤0.01% |
69,277
-234,989
| -77% | -$8.57M |
|
3413
United States Antimony
UAMY
$726M
| $2.61M | ﹤0.01% |
1,186,582
+1,085,789
| +1,077% | +$1.88M |
|
3414
CALL
NeoGenomics
NEO
$2.32B
| $2.61M | ﹤0.01% |
+275,000
| New | +$3.43M |
|
3415
PUT
Carpenter Technology
CRS
$23.6B
| $2.61M | ﹤0.01% |
14,400
+12,300
| +586% | +$2.37M |
|
3416
CALL
Williams-Sonoma
WSM
$27.7B
| $2.61M | ﹤0.01% |
16,500
-1,100
| -6% | -$213K |
|
3417
Harmony Biosciences
HRMY
$2.28B
| $2.61M | ﹤0.01% |
78,492
+72,159
| +1,139% | +$2.59M |
|
3418
Theravance Biopharma
TBPH
$885M
| $2.6M | ﹤0.01% |
291,534
+98,695
| +51% | +$918K |
|
3419
PUT
CAVA Group
CAVA
$7.82B
| $2.6M | ﹤0.01% |
30,100
+14,400
| +92% | +$1.56M |
|
3420
Pacific Biosciences
PACB
$435M
| $2.6M | ﹤0.01% |
2,204,044
-14,861,287
| -87% | -$22.8M |
|
3421
SiTime
SITM
$16.8B
| $2.6M | ﹤0.01% |
17,005
+9,661
| +132% | +$1.85M |
|
3422
LifeMD
LFMD
$151M
| $2.59M | ﹤0.01% |
476,462
-409,525
| -46% | -$2.32M |
|
3423
Omeros
OMER
$1.35B
| $2.59M | ﹤0.01% |
315,252
+229,581
| +268% | +$2.03M |
|
3424
Lakeland Industries
LAKE
$117M
| $2.59M | ﹤0.01% |
127,465
+99,682
| +359% | +$2.29M |
|
3425
Inspire Medical Systems
INSP
$1.78B
| $2.59M | ﹤0.01% |
16,246
+11,195
| +222% | +$2.03M |
|
Similar funds
Israel Englander's Q1 2025 Portfolio in Review
As of Q1 2025, Israel Englander held 6,639 positions worth $188B, down 8.2% from $205B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander withdrew a net $10.2B in Q1 2025, closing 852 positions and reducing 2,261 holdings. Its most notable exit was Verizon, an estimated $263M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 50% a quarter earlier, followed by Financials and Technology.
Against the trend, Israel Englander opened a new position in Blackrock worth $215M.
- Israel Englander's largest Q1 2025 buy was Blackrock: 227,394 shares worth $215M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $2.22B increase.
- Israel Englander's biggest Q1 2025 reduction was Broadcom, cutting an estimated $926M.
- Israel Englander fully exited Verizon in Q1 2025, selling an estimated $263M.
- Israel Englander's ten largest holdings make up 16% of its $188B portfolio in Q1 2025.
- Israel Englander opened 739 new positions and closed 852 in Q1 2025.
- Israel Englander's portfolio value fell 8.2% quarter-over-quarter to $188B.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.